clozapine

The drug is used in the treatment of schizophrenia in patients who do not respond to other antipsychotic medications. It is also used to treat severe disturbances in thinking, emotion, and behavior in individuals with Parkinson's disease who do not respond to other treatments.

Form: tablets, dispersible in the oral cavity

ATC: N05AH02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used in the treatment of patients with schizophrenia for whom other antipsychotic drugs have not been effective or have caused severe side effects. It is also used in the treatment of severe disturbances in thinking, emotion, and behavior in people with Parkinson's disease who do not respond to other treatments.

Form: tablets, dispersible in the oral cavity

ATC: N05AH02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used in the treatment of schizophrenia in patients who do not respond to other antipsychotic drugs. It is also used to treat severe disturbances in thinking, emotion, and behavior in individuals with Parkinson's disease, where other treatment methods have not been effective.

Form: tablets, dispersible in the oral cavity

ATC: N05AH02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to treat patients with schizophrenia who have not responded to other antipsychotic medications or who have experienced severe side effects. It is also used to treat severe disturbances in thinking, emotion, and behavior in individuals with Parkinson's disease who do not respond to other treatments.

Form: tablets, dispersible in the oral cavity

ATC: N05AH02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used in the treatment of schizophrenia in patients who do not respond to other antipsychotic drugs. It may also be used in the treatment of severe disturbances in thinking, emotion, and behavior in individuals with Parkinson's disease who do not respond to other treatments.

Form: tablets

ATC: N05AH02

Manufacturer: Accord Healthcare B.V.

The drug is used in the treatment of schizophrenia in patients who do not respond to other antipsychotic medications. In doses of 25 mg, 50 mg, and 100 mg, it is also used to treat severe disturbances in thinking, emotion, and behavior in individuals with Parkinson's disease who do not respond to other treatments.

Form: tablets

ATC: N05AH02

Manufacturer: Accord Healthcare B.V.

It is used in the treatment of schizophrenia in patients for whom other antipsychotic drugs have not been effective or have caused severe side effects. In the case of Parkinson's disease, the drug helps in the treatment of severe disturbances in thinking, emotions, and behavior.

Form: tablets

ATC: N05AH02

Manufacturer: Accord Healthcare B.V.

The medicinal product is used in the treatment of schizophrenia in patients who do not respond to other antipsychotic drugs. In doses of 25 mg, 50 mg, and 100 mg, it is also used to treat severe disturbances of thought, emotion, and behavior in individuals with Parkinson's disease who do not respond to other treatments.

Form: tablets

ATC: N05AH02

Manufacturer: Accord Healthcare B.V.

The medicinal product is used in patients with schizophrenia for whom other medicines have not been effective or have caused severe side effects. It is also used in the treatment of severe disturbances of thought, emotion, and behavior in people with Parkinson's disease who do not respond to other treatments.

Form: tablets

ATC: N05AH02

Manufacturer: HASCO-LEK S.A. Pharmaceutical Production Enterprise

The medicinal product is used in the treatment of patients with schizophrenia who have not responded to other medications or who have experienced severe adverse reactions. It is also used in the treatment of severe disturbances of thought, emotion, and behavior in individuals with Parkinson's disease who do not respond to other treatments.

Form: tablets

ATC: N05AH02

Manufacturer: HASCO-LEK S.A. Pharmaceutical Production Enterprise

The medicine is used in the treatment of schizophrenia in patients who do not respond to other antipsychotic drugs. It is also used to treat severe disturbances in thinking, emotions, and behavior in individuals with Parkinson's disease, where other treatment methods have not been effective.

Form: tablets

ATC: N05AH02

Manufacturer: Egis Pharmaceuticals PLC

The medicine is used to treat schizophrenia in patients who do not respond to other antipsychotic drugs. It is also used to treat severe disturbances in thinking, emotion, and behavior in individuals with Parkinson's disease, where other treatment methods have not been effective.

Form: tablets

ATC: N05AH02

Manufacturer: Egis Pharmaceuticals PLC

Paxifar is used to treat schizophrenia in patients who do not respond to other antipsychotic medications. In doses of 25 mg, 50 mg, and 100 mg, it is also used to treat severe disturbances in thinking, emotion, and behavior in individuals with Parkinson's disease when other methods have proven ineffective.

Form: tablets

ATC: N05AH02

Manufacturer: Laboratori Fundació Dau

The medicine is used to treat patients with schizophrenia for whom other antipsychotic drugs have not been effective or have caused severe side effects. In patients with Parkinson's disease, it is used to treat severe disturbances in thinking, emotions, and behavior when other methods have proven ineffective.

Form: tablets

ATC: N05AH02

Manufacturer: Laboratori Fundació Dau

The medicine is used to treat patients with schizophrenia for whom other medicines have not been effective or have caused severe side effects. It may also be used to treat severe disturbances in thinking, emotion, and behavior in people with Parkinson's disease when other methods have failed.

Form: tablets

ATC: N05AH02

Manufacturer: Laboratori Fundació Dau

The medicine is used to treat patients with schizophrenia who have not responded to other antipsychotic medications or who have experienced severe side effects. At doses of 25 mg, 50 mg, and 100 mg, it is also used to treat severe disturbances in thinking, emotion, and behavior in individuals with Parkinson's disease when other methods have failed.

Form: tablets

ATC: N05AH02

Manufacturer: Laboratori Fundació Dau

The medicine is used to treat schizophrenia in patients who do not respond to other antipsychotic drugs. It is also used to treat severe disturbances in thinking, emotion, and behavior in individuals with Parkinson's disease who do not respond to other treatment methods.

Form: tablets

ATC: N05AH02

Manufacturer: Symphar Sp. z o.o.

The medicine is used to treat schizophrenia in patients who do not respond to other antipsychotic drugs. It is also intended for the treatment of severe disturbances in thinking, emotion, and behavior in individuals with Parkinson's disease, where other treatment methods have not been effective.

Form: tablets

ATC: N05AH02

Manufacturer: Symphar Sp. z o.o.

The drug is used in the treatment of schizophrenia in patients who do not respond to other antipsychotic medications. It is also used to treat severe disturbances in thinking, emotion, and behavior in individuals with Parkinson's disease, where other medications have not been effective.

Form: tablets

ATC: N05AH02

Manufacturer: Symphar Sp. z o.o.